Moderators and Mediators of Therapy for Conduct Disorder
行为障碍治疗的调节者和调解者
基本信息
- 批准号:6815067
- 负责人:
- 金额:$ 52.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-12-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
EXCEED THE SPACE PROVIDED. This is a revised application for a Competing Continuation. The prior version received a priority score of 193 in October 2001. The revised application addresses issues raised by the 6 reviewers. The overarching goal of this study is to improve the effectiveness of treatment of children referred for Conduct Disorder. The study focuses on understanding how treatment produces changes (mediators) and factors that contribute to outcome (moderators). The model underlying the study is that therapeutic change is influenced by characteristics that children, parents, and families "bring with" them to treatment, by characteristics that emerge during the treatment process (e.g., alliance, adherence), and by the intervention and associated features (e.g., therapist behavior, characteristics). The proposed study focuses on the first two components and will: 1) identify child, parent, and family factor s that contribute to therapeutic change and 2) test key processes during the course of treatment that explain therapeutic change. Children (N=200, ages 6-12, including European and African American families) referred to outpatient treatment and who meet diagnostic criteria for Conduct Disorder will participate. All children and parents well receive problem-solving skills training and parent management training as a combined treatment. The central predictions are that: 1) responsiveness to treatment will be influenced by child dysfunction and impairment, parent dysfunction and stress, and adverse family relations in the home and by initial parent expectancies about treatment processes and outcome, and 2) therapeutic change will be mediated by a positive parent-therapist relationship, few perceived parent barriers to treatment during treatment, and parent and child adherence and compliance with treatment. The study will also permit evaluation of the predictions across the two ethnicities. Apart from improving the effectiveness of treatment for Conduct Disorder, the study is intended to advance a heuristic model for child therapy research more generally. The model conceptualizes antecedents, emerging processes, and interventions as sources of influence on outcome, Also, the design of the study permits evaluation of processes and causal models to help explain the processes of change. PERFORMANCE KEY PERSONNEL ========================================Section End===========================================
超出所提供的空间。 这是一份修改后的竞争延续申请。2001年10月,前一个版本获得了193分的优先级。修订后的申请解决了6名审评员提出的问题。本研究的总体目标是提高治疗行为障碍儿童的有效性。这项研究的重点是了解治疗如何产生变化(介质)和影响结果的因素(调节剂)。这项研究的基础模型是,治疗变化受到儿童、父母和家庭“带来”治疗的特征的影响,受到治疗过程中出现的特征的影响(例如,联盟、遵守),以及通过干预和相关特征(例如,治疗师行为,特征)。拟议的研究侧重于前两个组成部分,并将:1)确定有助于治疗变化的儿童,父母和家庭因素,2)在治疗过程中测试解释治疗变化的关键过程。 儿童(N=200,6-12岁,包括欧洲和非洲裔美国家庭)转诊到门诊治疗,并符合行为障碍的诊断标准将参与。所有儿童和家长都接受解决问题技能培训和家长管理培训,作为一种综合治疗。核心预测是:1)对治疗的反应性将受到儿童功能障碍和损伤、父母功能障碍和压力、家庭中不利的家庭关系以及父母对治疗过程和结果的最初期望的影响,以及2)治疗变化将由积极的父母-治疗师关系介导,在治疗期间很少感知到父母对治疗的障碍,以及父母和孩子对治疗的依从性。这项研究还将允许对两个种族的预测进行评估。 除了提高行为障碍治疗的有效性外,这项研究还旨在为更普遍的儿童治疗研究提出一个启发式模型。该模型将前因、新兴过程和干预措施概念化为对结果的影响来源,此外,研究的设计允许评估过程和因果模型,以帮助解释变化的过程。性能关键人员=
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN KAZDIN其他文献
ALAN KAZDIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN KAZDIN', 18)}}的其他基金
Feasibility of Online Parent Training for the Treatment of Conduct Problems
处理行为问题的在线家长培训的可行性
- 批准号:
8660084 - 财政年份:2012
- 资助金额:
$ 52.06万 - 项目类别:
Feasibility of Online Parent Training for the Treatment of Conduct Problems
处理行为问题的在线家长培训的可行性
- 批准号:
8228637 - 财政年份:2012
- 资助金额:
$ 52.06万 - 项目类别:
Feasibility of Online Parent Training for the Treatment of Conduct Problems
处理行为问题的在线家长培训的可行性
- 批准号:
8500456 - 财政年份:2012
- 资助金额:
$ 52.06万 - 项目类别:
Moderators and Mediators of Therapy for Conduct Disorder
行为障碍治疗的调节者和调解者
- 批准号:
6679952 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
NEW TREATMENT DELIVERY MODEL FOR ANTISOCIAL CHILDREN
针对反社会儿童的新治疗模式
- 批准号:
2723733 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
NEW TREATMENT DELIVERY MODEL FOR ANTISOCIAL CHILDREN
针对反社会儿童的新治疗模式
- 批准号:
6126208 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
Moderators and Mediators of Therapy for Conduct Disorder
行为障碍治疗的调节者和调解者
- 批准号:
6571738 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
Moderators and Mediators of Therapy for Conduct Disorder
行为障碍治疗的调节者和调解者
- 批准号:
6993602 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
NEW TREATMENT DELIVERY MODEL FOR ANTISOCIAL CHILDREN
针对反社会儿童的新治疗模式
- 批准号:
6330298 - 财政年份:1998
- 资助金额:
$ 52.06万 - 项目类别:
相似海外基金
Inflammation Resolving Lipid Mediators: Novel Therapy for Alcohol AssociatedLiver Disease
消炎脂质介质:酒精相关性肝病的新疗法
- 批准号:
10590047 - 财政年份:2023
- 资助金额:
$ 52.06万 - 项目类别:
Interpersonal problems in Borderline Personality Disorder: Mediators for change during Dialectical Behavioural Therapy
边缘性人格障碍中的人际问题:辩证行为治疗中改变的中介
- 批准号:
428879 - 财政年份:2019
- 资助金额:
$ 52.06万 - 项目类别:
Studentship Programs
Elucidation of the role of nitric oxide-related mediators for the enhancement of photodynamic therapy
阐明一氧化氮相关介质在增强光动力治疗中的作用
- 批准号:
19K16751 - 财政年份:2019
- 资助金额:
$ 52.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Efficacy and neural mediators of response to Trauma Management Therapy for PTSD
创伤后应激障碍 (PTSD) 创伤管理疗法的疗效和神经调节因子
- 批准号:
10663775 - 财政年份:2018
- 资助金额:
$ 52.06万 - 项目类别:
Development of disease-specific therapy based on polycystic kidney disease pathophysiology focusing on lipid mediators
基于多囊肾病病理生理学的疾病特异性治疗的开发,重点关注脂质介质
- 批准号:
17K10150 - 财政年份:2017
- 资助金额:
$ 52.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Intestinal tissue-resident memory T cells as mediators of inflammatory bowel disease and possible targets of etrolizumab therapy
肠道组织驻留记忆 T 细胞作为炎症性肠病的介质和 etrolizumab 治疗的可能靶点
- 批准号:
356486795 - 财政年份:2017
- 资助金额:
$ 52.06万 - 项目类别:
Research Fellowships
Therapy of Hepatocellular Carcinoma through targeted inhibition of the cell cycle mediators Cyclin E1 and Cdk2 in mouse models
通过靶向抑制小鼠模型中的细胞周期介质 Cyclin E1 和 Cdk2 来治疗肝细胞癌
- 批准号:
271777553 - 财政年份:2015
- 资助金额:
$ 52.06万 - 项目类别:
Research Grants
Development of therapy targeting orphan GPCR-related lipid mediators for prevention of bone destruction
开发针对孤儿 GPCR 相关脂质介质的疗法以预防骨质破坏
- 批准号:
20390508 - 财政年份:2008
- 资助金额:
$ 52.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




